Aquinox Pharms

AQXP NASDAQ
2.380
0.000
0.00%
Opening 14:05 06/25 EDT
Open
2.380
Prev Close
2.380
High
2.380
Low
2.310
Volume
9.69K
Avg Vol (3M)
46.14K
52 Week High
15.49
52 Week Low
1.960
% Turnover
0.04%
Market Cap
56.02M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Aquinox Pharms AQXP stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Company's primary focus is anti-inflammatory product candidates targeting the Src Homology 2 (SH2)-containing inositol-5-phosphatase 1 (SHIP1) enzyme, which is a regulator of a cellular signaling pathway in immune cells, known as the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) pathway. Its product candidate, AQX-1125, is a small molecule activator of SHIP1 suitable for oral, once daily dosing. The Company is developing AQX-1125 as a treatment in interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic inflammatory disease of the bladder. AQX-1125 is a SHIP1 activator that has demonstrated preliminary safety, anti-inflammatory potential and drug properties in multiple preclinical studies.
MORE >

Recently

Name
Price
%Change